Literature DB >> 18088573

Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency.

Yasuhiro Maeda1, Tetsuya Ito, Hironori Ohmi, Kyoko Yokoi, Yoko Nakajima, Akihito Ueta, Yukihisa Kurono, Hajime Togari, Naruji Sugiyama.   

Abstract

Due to its increased concentration in blood, 3-hydroxyisovalerylcarnitine (C5OH-I) is an important indicator for the diagnosis of organic acidemias in newborns. However, C5OH-I has not been used as a standard in tandem mass spectrometric (MS/MS) assays because its isolation is difficult. We developed a new synthesis of C5OH-I and investigated its behavior by MS/MS. A method using the multiple reaction monitoring (MRM) mode of MS/MS with HPLC was developed which provides high accuracy, precision and reproducibility. Acylcarnitine profiles in the serum and urine of a patient with multiple carboxylase deficiency (MCD) showed increased levels compared to a healthy patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18088573     DOI: 10.1016/j.jchromb.2007.11.037

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  13 in total

1.  Application of a second-tier newborn screening assay for c5 isoforms.

Authors:  T Cloppenborg; N Janzen; Hj Wagner; U Steuerwald; M Peter; Am Das
Journal:  JIMD Rep       Date:  2013-11-06

2.  Mass Spectral Library of Acylcarnitines Derived from Human Urine.

Authors:  Xinjian Yan; Sanford P Markey; Ramesh Marupaka; Qian Dong; Brian T Cooper; Yuri A Mirokhin; William E Wallace; Stephen E Stein
Journal:  Anal Chem       Date:  2020-04-23       Impact factor: 6.986

3.  Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Lindsay Pack; Jeffery Moran; Donald M Mock
Journal:  Anal Chem       Date:  2010-05-15       Impact factor: 6.986

4.  Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans.

Authors:  Donald M Mock; Shawna L Stratton; Thomas D Horvath; Anna Bogusiewicz; Nell I Matthews; Cindy L Henrich; Amanda M Dawson; Horace J Spencer; Suzanne N Owen; Gunnar Boysen; Jeffery H Moran
Journal:  J Nutr       Date:  2011-09-14       Impact factor: 4.798

Review 5.  3-Methylglutaric acid in energy metabolism.

Authors:  Dylan E Jones; Leanne Perez; Robert O Ryan
Journal:  Clin Chim Acta       Date:  2019-11-12       Impact factor: 3.786

6.  Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS.

Authors:  Thomas D Horvath; Nell I Matthews; Shawna L Stratton; Donald M Mock; Gunnar Boysen
Journal:  Anal Bioanal Chem       Date:  2011-09-03       Impact factor: 4.142

7.  Quantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Suzanne N Owen; Donald M Mock; Jeffery H Moran
Journal:  Anal Chem       Date:  2010-10-28       Impact factor: 6.986

8.  A pilot study on machine learning approach to delineate metabolic signatures in intellectual disability.

Authors:  Vidya Nikam; Suvidya Ranade; Naushad Shaik Mohammad; Mohan Kulkarni
Journal:  Int J Dev Disabil       Date:  2019-04-15

9.  Metabolic Consequences of Chronic Alcohol Abuse in Non-Smokers: A Pilot Study.

Authors:  Obiamaka Obianyo; Yan Liang; Ellen L Burnham; Ashish Mehta; Youngja Park; Karan Uppal; Frank L Harris; Dean P Jones; Lou Ann S Brown
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

10.  Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines.

Authors:  Justin J J van der Hooft; Lars Ridder; Michael P Barrett; Karl E V Burgess
Journal:  Front Bioeng Biotechnol       Date:  2015-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.